Wright Medical Group, Inc. is a global orthopaedic device company specializing in the design, manufacture and marketing of reconstructive joint devices and bio-orthopaedic materials. Reconstructive joint devices are used to replace knee, hip and other joints that have deteriorated through disease or injury. Bio-orthopaedic materials are used to replace damaged or diseased bone and to stimulate natural bone growth.
Be they in the hardware development side or the chemical development side, these companies have the same goal; to increase the disease detection threshold and to increase the productivity of labs so more tests can be performed in less time. Each company tends to go about this goal in a different way. One company is involved heavily in gene testing and therapy, another is in manufacturing better isotopes to be used in nuclear medicine. Also, some companies have their hand in the home-testing fields for such things as Human Immunodeficiency Virus (HIV, the virus that causes AIDS) and other diseases.
|
| Totals |
Company |
Industry |
| Sales: |
$745.0 Mil |
$10,244.3 Mil |
| Market Cap: |
$2,072.4 Mil |
$72,197.8 Mil |
| Analysts Recommendation: |
Strong Buy |
Buy |
|
|
| Averages |
Company |
Industry |
 |
| Growth |
| Historic Revenue: |
7.9% |
11.3% |
| Estimated Revenue: |
8.5% |
19.5% |
| Historic Earnings: |
N/A |
(312.5%) |
| Estimated Earnings: |
N/A |
100.6% |
| Stock Price (1 Year): |
(34.3%) |
34.9% |
| Cash per Share: |
(60.2%) |
15.9% |
| Dividend: |
N/A |
N/A |
| Price |
| Trailing PE: |
N/A |
N/A |
| Forward PE: |
122.6 |
40.0 |
| Price-to-Sales: |
2.8 |
N/A |
| Price-to-Book: |
3.5 |
(20.9) |
| Dividend Yield: |
N/A |
N/A |
| Market Cap: |
$2,072.4 Mil |
$3,281.7 Mil |
| Operations |
| Net Margin: |
(27.2%) |
(848.1%) |
| Gross Margin: |
78.4% |
60.3% |
| Return on Equity: |
(.3) |
(1.0) |
| Return on Assets: |
(.1) |
(.9) |
| Balance Sheet |
| Current Ratio: |
1.4 |
3.2 |
| Quick Ratio: |
1.0 |
2.6 |
| Cash Ratio: |
.4 |
1.8 |
| Debt-to-Equity: |
2.6 |
3.2 |
| Interest Coverage: |
(.1) |
(1.3) |
| Technicals |
| Relative-Strength Index: |
43.7 |
N/A |
|
|
|
